We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

41 hedge funds and large institutions have $3.7M invested in CERo Therapeutics Warrants in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

17% more funds holding

Funds holding: 35 → 41 (+6)

12% less capital invested

Capital invested by funds: $4.21M → $3.7M (-$509K)

Holders
41
Holders Change
+6
Holders Change %
+17.14%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
1
Closed
3
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$53.7K
2
SRCM
Sage Rock Capital Management
New York
+$14.8K
3
AGM
Alpine Global Management
New York
+$8.88K
4
HIM
HGC Investment Management
Ontario, Canada
+$8.06K
5
SSA
Schonfeld Strategic Advisors
New York
+$5.8K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$71K
2
CL
CSS LLC
Illinois
-$19K
3
BI
Bulldog Investors
New Jersey
-$482
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
26
Bulldog Investors
New Jersey
$5K -$482 -2,988 -5%
TCM
27
Tenor Capital Management
New York
$5K – – –
KL
28
KIM LLC
Kansas
$5K +$8.06K +50,000 New
SSA
29
Schonfeld Strategic Advisors
New York
$4K +$5.8K +36,000 New
HF
30
HRT Financial
New York
$3K – – –
Hudson Bay Capital Management
31
Hudson Bay Capital Management
Connecticut
$3K – – –
RCM
32
Rivernorth Capital Management
Florida
$3K – – –
WA
33
Whitebox Advisors
Minnesota
$3K – – –
VF
34
Virtu Financial
New York
$2K – +2 +0%
DCM
35
Dupont Capital Management
Delaware
$1K – – –
WP
36
Woodline Partners
California
$1K – – –
RA
37
Ramius Advisors
New York
$1K +$1.69K +10,500 New
FTUS
38
Flow Traders U.S.
New York
$1K +$1.97K +12,196 New
SCM
39
Segantii Capital Management
Hong Kong
$50 – – –
MF
40
Magnetar Financial
Illinois
$2 +$3.31K +20,550 New
Citadel Advisors
41
Citadel Advisors
Florida
– -$71K -375,000 Closed
CL
42
CSS LLC
Illinois
– -$19K -86,594 Closed
SCC
43
Spring Creek Capital
Kansas
– -$11K -50,000 Closed
RCM
44
Robinson Capital Management
Michigan
– +$526 +3,265 New
1
2

CEROW Hedge Fund Activity: Q2 2022 in Review

41 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q2 2022, worth a combined $3.7M — down 12% from $4.21M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CEROW positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $53.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $71K sold.

  • 41 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q2 2022, up from 35 in Q1 2022.
  • Funds reported $3.7M of CERo Therapeutics Warrants stock for Q2 2022, down 12% quarter-over-quarter.
  • 9 funds opened new CERo Therapeutics Warrants positions in Q2 2022 and 3 closed out, a net change of +6 holders.
  • The largest CERo Therapeutics Warrants buyer in Q2 2022 was Clear Street, an estimated $53.7K added.
  • The largest CERo Therapeutics Warrants seller in Q2 2022 was Citadel Advisors, an estimated $71K sold.

Based on aggregated 13F filings for Q2 2022.